A PYMNTS Company

US: Pfizer to pay $17 billion for Hospira

By  |  February 5, 2015

Pfizer announced it would buy Hospira for about $15 billion on Thursday.

Pfizer is known for prescription medicines like Viagra and Lyrica , but many of its biggest brands, including Lipitor and Celebrex have lost patent protection. Hospira makes generic versions of injectable drugs that are widely used in hospitals.

The proposed acquisition is Pfizer’s largest since the New York company failed in its attempt to buy AstraZeneca last year.

Pfizer expects the deal, which requires regulatory and shareholder approvals, to close later this year.

 

Full Content: Bloomberg

 

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.